Myelofibrosis (MF) clinical trials at UC Health
1 in progress, 0 open to eligible people
A Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis
Sorry, in progress, not accepting new patients
This is a Phase 2, single-arm, open-label, multicenter study evaluating efficacy, safety and tolerability of navitoclax added to ruxolitinib in participants with myelofibrosis.